Lina Prasmickaite

Forsker
ved Seksjon for tumorbiologi ved Oslo universitetssykehus HF

Resultater Resultater

Preclinical Efficacy of Cabazitaxel Loaded Poly (2-alkyl cyanoacrylate) Nanoparticle Variants.

Valsalakumari, Remya; Pandya, Abilash D; Prasmickaite, Lina; Kvalvaag, Audun Sverre Myrset; Myrann, Anne Grethe; Åslund, Andreas K. O.; Kjos, Marianne Steinsvik; Fontecha-Cuenca, Cristina; Haroon, Hajira B.; Ribeiro, Ana R.S. mfl.. 2024, International Journal of Nanomedicine. SINTEF, UIO, OUSVitenskapelig artikkel

Breast cancer patient-derived explant cultures recapitulate in vivo drug responses.

Pettersen, Solveig; Øy, Geir Frode; Egeland, Eivind Valen; Juell, Siri; Engebråten, Olav; Mælandsmo, Gunhild Mari; Prasmickaite, Lina. 2023, Frontiers in Oncology. UIT, UIO, OUSVitenskapelig artikkel

A combined experimental-computational approach uncovers a role for the Golgi matrix protein Giantin in breast cancer progression.

Ghannoum, Salim; Fantini, Damiano; Zahoor, Muhammad; Reiterer, Veronika; Phuyal, Santosh; Leoncio Netto, Waldir; Sørensen, Øystein; Iyer, Arvind; Sengupta, Debarka; Prasmickaite, Lina mfl.. 2023, PLoS Computational Biology. UIT, LUI, MEDINNSBRU, NU, UIO, OUS, UdL, IIT-DVitenskapelig artikkel

AXL inhibition improves BRAF-targeted treatment in melanoma.

Nyakas, Marta Sølvi; Fleten, Karianne Giller; Haugen, Mads Haugland; Engedal, Nikolai; Sveen, Christina; Farstad, Inger Nina; Flørenes, Vivi Ann; Prasmickaite, Lina; Mælandsmo, Gunhild Mari; Seip, Kotryna. 2022, Scientific Reports. UIT, UIO, OUSVitenskapelig artikkel

Detection of phenotype-specific therapeutic vulnerabilities in breast cells using a CRISPR loss-of-function screen.

Barkovskaya, Anna; Goodwin, Craig; Seip, Kotryna; Hilmarsdòttir, Bylgja; Pettersen, Solveig; Stalnecker, Clint; Engebråten, Olav; Briem, Eirikur; Der, Channing J; Moestue, Siver Andreas mfl.. 2021, Molecular Oncology. UIT, HÊ, LANDSPITAL, NORD, NTNU, UIO, OUS, UONCACHVitenskapelig artikkel

1 - 5 av 38 | Neste | Siste »